Delivery Order W81XWH16D0009-0002
Award Date
9/19/16
Potential Completion Date
9/18/19
Potential Value
$1.7M
Federal Agency
Medical Command
Awardee
Inbios International Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Seattle, WA 98104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,508,014.60, was issued by the Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for Information and Communications Technology (ICT) Development on a Cost-Plus-Fixed-Fee (CPFF) basis, with a completion date of July 20, 2019. Inbios, a Subchapter S Corporation, is a manufacturer of immunodiagnostic devices for infectious diseases. This contract award...
This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the U.S. Army Medical Command (MEDCOM), is for a Small Business Innovation Research (SBIR) Phase II project, valued at $891,867.91. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the ultimate completion date is January 14, 2020. Inbios International Inc. is a specialized manufacturer of...
This federal contract award, valued at $4,708.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the procurement of "TEST KIT,VISCERAL L" and has a completion date of June 24, 2024. Inbios International Inc. is a veteran-owned, for-profit organization that specializes in the design, development, and manufacture of immunodiagnostic...
This federal contract award, HHSD2002017M93163P, was made by the Centers for Disease Control and Prevention (CDC) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $198,492.00 firm fixed-price purchase order is for INBIOS EQUIPMENT, with an ultimate completion date of July 14, 2017. The contract was awarded on March 9, 2017, and was not set aside for any specific business type. Inbios International is a key partner to multiple...
This federal contract award, W81XWH15P0522, was made by the U.S. Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $95,000.00 firm fixed-price purchase order contract was set aside for small businesses and has an ultimate completion date of October 15, 2015. The contract is for NORO-RD products, which likely refers to diagnostic devices or related medical technology. Inbios International is a critical...
This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...
This federal contract award by the Centers for Disease Control and Prevention (CDC) is for the procurement of ELISA detection kits from Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $85,485.00, is a firm fixed-price purchase order with an ultimate completion date of April 30, 2020. Inbios is a critical partner to the government, particularly during the COVID-19 pandemic, having secured numerous contracts with...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a cost-plus-fixed-fee definitive contract worth $7,735,010.61 to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the development of point-of-care and laboratory-based immunoassays for the presumptive diagnosis of Zika virus infection. This contract is not set aside. Inbios is a key partner to...
Inbios International, Inc. was awarded a definitive cost-plus-fixed-fee contract valued at $11,988,614 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The base period award is to provide point-of-care immunoassay for diagnosis of inhalational anthrax, as requested in the original solicitation. Inbios, a minority-owned small business based in Seattle, Washington, will manufacture and deliver rapid diagnostic tests to detect...